XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Condensed Consolidated Statements of Operations [Abstract]        
Net sales $ 186,176,000 $ 171,862,000 $ 564,249,000 $ 528,206,000
Cost of goods sold 141,294,000 141,819,000 448,916,000 430,448,000
Gross profit 44,882,000 30,043,000 115,333,000 97,758,000
Operating expenses:        
General and administrative 16,212,000 15,198,000 47,934,000 42,125,000
Sales and marketing 5,621,000 5,931,000 16,904,000 17,038,000
Research and development 3,008,000 2,539,000 7,884,000 7,352,000
Foreign exchange impact of lease liabilities and forward contracts 2,460,000 (3,149,000) 18,966,000 (2,659,000)
Total operating expenses 27,301,000 20,519,000 91,688,000 63,856,000
Operating income 17,581,000 9,524,000 23,645,000 33,902,000
Other expenses:        
Interest expense, net 14,435,000 18,297,000 43,004,000 45,400,000
Change in fair value of compound net derivative liability (260,000) 1,160,000 (2,460,000) 1,690,000
Loss on extinguishment of debt 0 0 0 168,000
Total other expenses 14,175,000 19,457,000 40,544,000 47,258,000
Income (loss) before income tax expense 3,406,000 (9,933,000) (16,899,000) (13,356,000)
Income tax expense 1,115,000 37,281,000 1,849,000 37,226,000
Net income (loss) $ 2,291,000 $ (47,214,000) $ (18,748,000) $ (50,582,000)
Basic net income (loss) per share (in Dollars per share) $ 0.12 $ (2.4) $ (0.95) $ (2.58)
Diluted net income (loss) per share (in Dollars per share) $ 0.11 $ (2.4) $ (0.95) $ (2.58)
Weighted average number of shares outstanding:        
Basic (in Shares) 19,783,170 19,634,306 19,739,481 19,580,960
Diluted (in Shares) 20,416,958 19,634,306 19,739,481 19,580,960